Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Passera

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Hepatology International|July 24, 2015
Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluationSilvia Gaia, Antonella Olivero, Antonina Smedile, et al.
Annals of Hematology|July 11, 2018
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patientsLucia Brunello, Roberto Passera, Chiara Maria Dellacasa, et al.
Surgical Endoscopy|December 8, 2016
Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial)Alberto Arezzo, Carmen Balague, Eduardo Targarona, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Serena Grimaldi, Marco Oderda, et al.
Cancer|May 14, 2011
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemiaAnna Guidetti, Carmelo Carlo-Stella, Marco Ruella, et al.
American Journal of Hematology|August 14, 2013
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapyAlessandro Rambaldi, Cristina Boschini, Giuseppe Gritti, et al.
Haematologica|July 13, 2014
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesSimona Caltagirone, Marina Ruggeri, Simona Aschero, et al.
Bone Marrow Transplantation|April 15, 2018
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Roberto Passera, Enrico Maffini, et al.
La Radiologia Medica|December 16, 2024
Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)Monica Finessi, Martina Cioffi, Serena Grimaldi, et al.
Minerva Urology and Nephrology|October 23, 2025
The national and subnational burden of prostate cancer in Italy from 1990 to 2021: results from the Global Burden of Disease Study 2021Elisa Fabbro, Giulia Zamagni, Giulia Carreras, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Hepatology International|July 24, 2015
Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluationSilvia Gaia, Antonella Olivero, Antonina Smedile, et al.
Annals of Hematology|July 11, 2018
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patientsLucia Brunello, Roberto Passera, Chiara Maria Dellacasa, et al.
Surgical Endoscopy|December 8, 2016
Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial)Alberto Arezzo, Carmen Balague, Eduardo Targarona, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Serena Grimaldi, Marco Oderda, et al.
Cancer|May 14, 2011
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemiaAnna Guidetti, Carmelo Carlo-Stella, Marco Ruella, et al.
American Journal of Hematology|August 14, 2013
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapyAlessandro Rambaldi, Cristina Boschini, Giuseppe Gritti, et al.
Haematologica|July 13, 2014
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesSimona Caltagirone, Marina Ruggeri, Simona Aschero, et al.
Bone Marrow Transplantation|April 15, 2018
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Roberto Passera, Enrico Maffini, et al.
La Radiologia Medica|December 16, 2024
Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)Monica Finessi, Martina Cioffi, Serena Grimaldi, et al.
Minerva Urology and Nephrology|October 23, 2025
The national and subnational burden of prostate cancer in Italy from 1990 to 2021: results from the Global Burden of Disease Study 2021Elisa Fabbro, Giulia Zamagni, Giulia Carreras, et al.
Pageof 17